Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12(1):1–30.

Article  PubMed  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20(3):343–72.

Article  PubMed  PubMed Central  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2. Esophagus. 2023;20(3):373–89.

Article  PubMed  PubMed Central  Google Scholar 

Toh Y, Oki E, Minami K, et al. Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values. Esophagus. 2010;7:37–43.

Article  Google Scholar 

Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18(12):3353–61.

Article  PubMed  Google Scholar 

Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8–10.

Article  CAS  PubMed  Google Scholar 

Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8(6):378–82.

Article  CAS  PubMed  Google Scholar 

Jamel S, Tukanova K, Markar S. Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: a systematic review. World J Gastrointest Oncol. 2019;11(9):741–9.

Article  PubMed  PubMed Central  Google Scholar 

Morinaga T, Iwatsuki M, Yamashita K, Harada K, Kurashige J, Nagai Y, et al. Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma. Surg Today. 2021;51(5):798–806.

Article  CAS  PubMed  Google Scholar 

Tsai PC, Chien HC, Hsu PK, Hung JJ, Huang CS, Hsu WH, et al. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy. BMC Cancer. 2022;22(1):637.

Article  PubMed  PubMed Central  Google Scholar 

Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection. Ann Surg Oncol. 2020;27(3):651–9.

Article  PubMed  Google Scholar 

Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21(1):e18–28.

Article  PubMed  Google Scholar 

Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14(1):1–36.

Article  Google Scholar 

Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14(1):37–65.

Article  Google Scholar 

Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget. 2015;6(11):8491–524.

Article  PubMed  PubMed Central  Google Scholar 

Tosoian JJ, Gorin MA, Ross AE, Pienta KJ, Tran PT, Schaeffer EM. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations. Nat Rev Urol. 2017;14(1):15–25.

Article  CAS  PubMed  Google Scholar 

Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2010.

Google Scholar 

Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, et al. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. BMC Cancer. 2012;22(12):542.

Article  Google Scholar 

Nakanoko T, Morita M, Nakashima Y, et al. Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: historical changes and future perspectives in Japan. Esophagus. 2022;19(1):69–76.

Article  PubMed  Google Scholar 

Depypere L, Lerut T, Moons J, Coosemans W, Decker G, Van Veer H, et al. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road. Dis Esophagus. 2017;30(1):1–8.

CAS  PubMed  Google Scholar 

Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–16.

Article  CAS  PubMed  Google Scholar 

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47.

Article  CAS  PubMed  Google Scholar 

Hamai Y, Hihara J, Emi M, Furukawa T, Ibuki Y, Yamakita I, et al. Treatment outcomes and prognostic factors after recurrence of esophageal squamous cell carcinoma. World J Surg. 2018;42(7):2190–8.

Article  PubMed  Google Scholar 

Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62(11):685–92.

Article  PubMed  Google Scholar 

Nam SY, Jeon SW, Lee SJ, Kwon YH, Lee HS, Kim SK. Clinical factors to predict the response to concurrent chemoradiotherapy and survival in esophageal cancer patients. Gut Liver. 2020;14(4):450–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghaly G, Harrison S, Kamel MK, Rahouma M, Nasar A, Port JL, et al. Predictors of survival after treatment of oligometastases after esophagectomy. Ann Thorac Surg. 2018;105(2):357–62.

Article  PubMed  Google Scholar 

Liu Q, Chen J, Li B, Ye J, Wei S, Wang Y, et al. Local therapy for oligometastatic esophageal squamous cell carcinoma: a prospective, randomized, phase II clinical trial. Future Oncol. 2021;17(11):1285–93.

Article  CAS  PubMed  Google Scholar 

Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, CheckMate 648 Trial Investigators, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med. 2022;386(5):449–62.

Article  CAS  PubMed  Google Scholar 

Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, KEYNOTE-590 Investigators, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398(10302):759–71.

Article  CAS  PubMed  Google Scholar